Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-052784

COO, CFO acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kung Winston · COO, CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-19 Exercise or conversion : show line 1 in the form +5,000 $3.22 $16,100 6,600 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-19 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −5,000 214,034 D
Loading xslF345X03/doc4.xml…